Colin Devinant

Colin Devinant's practice centers on national and international patent and trade secret litigation before French courts and the Unified Patent Court.

He has experience working on contentious and noncontentious matters in France and abroad (Germany, U.S., UK) for start-ups and international groups involving patent rights across virtually all technical fields (mechanics, chemistry, electronics, cosmetics, packaging, transports, consumer products, medical devices, agrochemical products, construction, biosimilars, generics).

Colin focuses on patent validity and infringement litigation, SPCs (supplementary protection certificates), and compensation for employee inventions and patent ownership claims. He also drafts and negotiates confidentiality, license, research, and technology transfer agreements and performs IP due diligence in support of M&A deals.

Colin also advises on trade secret protection, in the context of litigation for trade secret breach and in setting in place appropriate corporate policies, and on plant variety rights.

Prior to joining Jones Day, Colin practiced patent litigation in the Paris office of a U.S.-based international law firm and interned at a leading French patent litigation firm in Paris. His previous experience also includes serving as an intern in the IP legal department of a French research university, where he drafted and negotiated research and development agreements, as well as for a French patent and trademark prosecution firm.

Colin is a regular speaker/author on patent litigation, notably saisie-contrefaçon, second medical use claims, software patents, generics, and the Unified Patent Court.

Colin is an active member of the International Association for the Protection of Intellectual Property (AIPPI) (Executive Committee, Patents and UPC Commissions, and 2025 president of the Young Members Group), the Young EPLAW (European Lawyers), and the French Association for the Protection of Intellectual Property (AFPPI).